Microbot Medical Inc expected to post a loss of 18 cents a share - Earnings Preview
21/03/2025 20:02
Microbot Medical Inc MBOT.OQ MBOT.O is expected to show no change in quarterly revenue when it reports results on March 25 (estimated) for the period ending December 31 2024 LSEG's mean analyst estimate for Microbot Medical Inc is for a loss of 18 cents per share. The one available analyst rating on the shares is "buy". The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Microbot Medical Inc is $9.00, above its last closing price of $1.66. This summary was machine generated March 21 at 20:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Microbot Medical
See all newsBrief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device
Brief: Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System
Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
Brief: Microbot Medical Continues Its 2025 Momentum Announces Key 2026 Milestones